Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1283658-71-8
1621616-14-5
1807503-87-2
1807521-04-5
2055042-62-9
1919044-99-7
2093197-98-7 | BDP FL-PEG5-acid | AA019E87 | MFCD30723280
2182601-68-7 | Dbco-peg4-dbco | AA019ECP | MFCD31536768
2006345-34-0 | BDP 581/591 alkyne | AA019EG0 | MFCD31580110
23168-76-5 | 2-(6-(4-Chlorophenyl)pyridin-2-yl)acetonitrile | AA019EK1 | MFCD20038568
1962973-02-9 | METHYL 6-(2-HYDROXY-2-METHYLPROPYL)NICOTINATE | AA019ENG | MFCD11139308
1517549-00-6 | 3-(4-Methoxybenzyl)-1,3,7-triazaspiro[4.5]decane-2,4-dione hydrochloride | AA019EQA | MFCD28992162
1406294-50-5 | 4-bromo-N-(2-chloro-4-iodophenyl)benzenesulfonamide | AA019ETJ | MFCD18958558
1003209-11-7 | 4H-Cyclopenta[4,5]thieno[2,3-d]pyrimidine-3(5H)-acetic acid, 6,7-dihydro-4-oxo-,1,1-dimethylethyl ester Key Physical Properties | AA019EX1 | MFCD07006495
387827-21-6 | Acetamide, N-[3-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]-,monohydrochloride | AA019EZT | MFCD29075573
6106-07-6 | L-Thyroxine sodium salt pentahydrate | AA019FTK | MFCD06408007